Zdrowie i gospodarka · 20/08/2024
FDA Clears PENNSAID Topical Solution 2% for Sale
The US Food and Drug Administration has ruled that PENNSAID (diclofenac sodium) Topical Solution 2% was not withdrawn from sale due to safety or effectiveness concerns, allowing it to remain on the market.